Mandate

Vinge advises SAGA Diagnostics AB on convertible note issue

September 28, 2023

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.

Vinge’s team consisted of Christian Lindhé, Sofie Nordgren and Agaton Lindgren.  

 

Related

Vinge has advised Cell Impact in connection with its rights issue

Vinge has advised Cell Impact AB (publ) in connection with a partly guaranteed rights issue which will provide Cell Impact with issue proceeds of SEK 129 million before deduction of transaction costs
December 06, 2023

Vinge has advised Triton in connection with sale of shares in Ambea AB (publ)

In total, 8.4 million shares were placed at a price of SEK 43.50 per share, corresponding to a total value of approximately SEK 365 million.
November 29, 2023

Vinge represents Lassie AB in a capital raising of SEK 260 million

Vinge has advised the pet insurance broker Lassie AB in connection with a capital raising of SEK 260 million in order to continue the expansion of the business.
November 29, 2023